Oncodesign Signs Partnership Agreement with Sanofi

News   Mar 28, 2013

 
Oncodesign Signs Partnership Agreement with Sanofi
 
 
 

RELATED ARTICLES

Metabolomic Profiling Identifies Taurine as New MS Therapeutic

News

New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.

READ MORE

Atomic Structure of 'Cold' Receptor Uncovered Aiding Therapeutic Targeting

News

A team of researchers have made the first determination of the atomic structure of Transient Receptor Potential Melastatin 8. This finding should boost ongoing efforts by scientists to target TRPM8 therapeutically.

READ MORE

Chemists Have Synthesized New Isoquinoline Derivatives

News

Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE